Opioid Safety: Balancing Benefits and Risks _ _____________________________________________________
(a) The patient’s name, address, telephone number, if a telephone number is available, gender, and date of birth; (b) A patient identifier such as a military identification number, driver’s license number, state identification card number, or other valid government-issued identification number, insurance identification num- ber, pharmacy software-generated patientspecific identifier, or other identifier associated specifically with the patient; (c) The name and address of the pharmacy dispensing the prescription drug; (d) The date the prescription is issued; (e) The date the prescription is filled; (f) The date the prescription is sold to the patient; (g) The number of refills authorized; (h) The prescription number of the prescription drug; (i) The National Drug Code number as published by the federal Food and Drug Administration of the prescription drug; (j) The strength of the prescription drug prescribed; (k) The quantity of the prescription drug prescribed and the number of days’ supply; (l) The prescriber’s name and National Provider Identifier number or Drug Enforcement Adminis- tration number when reporting a controlled sub- stance; and (m) Additional information as determined by the Health Information Technology Board and as pub- lished in the submitter guide for the prescription drug moniwtoring system. (4) Beginning July 1, 2018, a veterinarian licensed under the Veterinary Medicine and Surgery Practice Act shall be required to report the dispensing of prescription drugs which are controlled substances listed on Sched- ule II, Schedule III, Schedule IV, or Schedule V pursu- ant to section 28-405. Each such veterinarian shall indi- cate that the prescription is an animal prescription and shall include the following information in such report: (a) The first and last name and address, including city, state, and zip code, of the individual to whom the prescription drug is dispensed in accordance with a valid veterinarian-client-patient relationship; (b) Reporting status; (c) The first and last name of the prescribing veterinar- ian and his or her federal Drug Enforcement Ad- ministration number; (d) The National Drug Code number as published by the federal Food and Drug Administration of the prescription drug and the prescription number;
NEBRASKA REVISED STATUTE 71-2454
(1) Prescription drug monitoring; system established; provi- sions included; not public records. (2) An entity described in section 71-2455 shall establish a system of prescription drug monitoring for the purpos- es of (a) preventing the misuse of controlled substances that are prescribed, (b) allowing prescribers and dispens- ers to monitor the care and treatment of patients for whom such a prescription drug is prescribed to ensure that such prescription drugs are used for medically ap- propriate purposes, (c) providing information to im- prove the health and safety of patients, and (d) ensuring that the State of Nebraska remains on the cutting edge of medical information technology. (3) Such system of prescription drug monitoring shall be implemented as follows: Except as provided in subsec- tion (4) of this section, all prescription drug informa- tion shall be reported to the prescription drug moni- toring system. The prescription drug monitoring system shall include, but not be limited to, provisions that: (a) Prohibit any patient from opting out of the prescrip- tion drug monitoring system; (b) Require any prescription drug that is dispensed in this state or to an address in this state to be entered into the system by the dispenser or his or her del- egate no less frequently than daily after such pre- scription drug is sold, including prescription drugs for patients paying cash or otherwise not relying on a third-party payor for payment; (c) Allow all prescribers or dispensers of prescription drugs to access the system at no cost to such pre- scriber or dispenser; (d) Ensure that such system includes information relat- ing to all payors, including, but not limited to, the medical assistance program established pursuant to the Medical Assistance Act; and (e) Make the prescription drug information available to the statewide health information exchange de- scribed in section 71-2455 for access by its partici- pants if such access is in compliance with the privacy and security protections set forth in the provisions of the federal Health Insurance Portability and Ac- countability Act of 1996, Public Law 104-191, and regulations promulgated thereunder, except that if a patient opts out of the statewide health information exchange, the prescription drug information regard- ing that patient shall not be accessible by the partici- pants in the statewide health information exchange. (3) Except as provided in subsection (4) of this section, pre- scription drug information that shall be submitted elec- tronically to the prescription drug monitoring system shall be determined by the entity described in section 71-2455 and shall include, but not be limited to:
21
MDNE1526
Powered by FlippingBook